EA006158B1 - Производные 2h-1-бензопирана и содержащая их фармацевтическая композиция - Google Patents

Производные 2h-1-бензопирана и содержащая их фармацевтическая композиция Download PDF

Info

Publication number
EA006158B1
EA006158B1 EA200300727A EA200300727A EA006158B1 EA 006158 B1 EA006158 B1 EA 006158B1 EA 200300727 A EA200300727 A EA 200300727A EA 200300727 A EA200300727 A EA 200300727A EA 006158 B1 EA006158 B1 EA 006158B1
Authority
EA
Eurasian Patent Office
Prior art keywords
compound
phenyl
compounds
solution
ethoxy
Prior art date
Application number
EA200300727A
Other languages
English (en)
Russian (ru)
Other versions
EA200300727A1 (ru
Inventor
Маурицио Дельканале
Габриеле Амари
Элизабетта Армани
Маурицио Чивелли
Элизабетта Гальбиати
Original Assignee
КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP01101521A external-priority patent/EP1229036B1/en
Priority claimed from EP01118682A external-priority patent/EP1281710A1/en
Application filed by КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. filed Critical КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А.
Publication of EA200300727A1 publication Critical patent/EA200300727A1/ru
Publication of EA006158B1 publication Critical patent/EA006158B1/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30Oestrogens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32Antioestrogens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
EA200300727A 2001-01-24 2002-01-21 Производные 2h-1-бензопирана и содержащая их фармацевтическая композиция EA006158B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP01101521A EP1229036B1 (en) 2001-01-24 2001-01-24 2H-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof
EP01118682A EP1281710A1 (en) 2001-08-03 2001-08-03 2H-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof
PCT/EP2002/000567 WO2002059113A1 (en) 2001-01-24 2002-01-21 2h-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof

Publications (2)

Publication Number Publication Date
EA200300727A1 EA200300727A1 (ru) 2004-02-26
EA006158B1 true EA006158B1 (ru) 2005-10-27

Family

ID=26076450

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200300727A EA006158B1 (ru) 2001-01-24 2002-01-21 Производные 2h-1-бензопирана и содержащая их фармацевтическая композиция

Country Status (26)

Country Link
US (1) US6951883B2 (enExample)
EP (1) EP1355906B1 (enExample)
JP (1) JP4332349B2 (enExample)
CN (1) CN1261431C (enExample)
AT (1) ATE286894T1 (enExample)
AU (1) AU2002237282B2 (enExample)
BR (1) BR0207066A (enExample)
CA (1) CA2435775A1 (enExample)
CZ (1) CZ20032014A3 (enExample)
DE (1) DE60202590T2 (enExample)
DK (1) DK1355906T3 (enExample)
DZ (1) DZ3459A1 (enExample)
EA (1) EA006158B1 (enExample)
ES (1) ES2236485T3 (enExample)
HU (1) HUP0401018A3 (enExample)
IL (2) IL157065A0 (enExample)
MA (1) MA26982A1 (enExample)
MX (1) MXPA03006505A (enExample)
NO (1) NO327808B1 (enExample)
NZ (1) NZ527144A (enExample)
PL (1) PL365062A1 (enExample)
PT (1) PT1355906E (enExample)
SI (1) SI1355906T1 (enExample)
SK (1) SK287086B6 (enExample)
TN (1) TNSN03043A1 (enExample)
WO (1) WO2002059113A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8080675B2 (en) 2004-09-21 2011-12-20 Marshall Edwards, Inc. Chroman derivatives, medicaments and use in therapy
NZ553834A (en) * 2004-09-21 2010-03-26 Novogen Res Pty Ltd 7-hydroxy-3,4-diphenyl-chroman and chromene derivatives
EP1809618B1 (en) * 2004-09-21 2013-07-17 Marshall Edwards, Inc. Chroman derivatives, medicaments and use in therapy
AU2005201855B2 (en) * 2004-09-21 2012-03-29 Marshall Edwards, Inc. Chroman derived compounds and formulations thereof for use in therapy
JP4913056B2 (ja) * 2004-09-21 2012-04-11 マーシャル エドワーズ,インコーポレーテッド 置換クロマン誘導体、医薬品、および治療における使用
JP4976649B2 (ja) * 2004-09-21 2012-07-18 マーシャル エドワーズ,インク. 化合物
CN101444499B (zh) * 2007-11-26 2012-12-05 湘北威尔曼制药股份有限公司 一种化合物及其组合物的新用途
ES2773732T3 (es) 2010-11-01 2020-07-14 Mei Pharma Inc Composiciones de isoflavonoides y procedimientos para el tratamiento del cáncer
EA031077B1 (ru) 2013-06-19 2018-11-30 Серагон Фармасьютикалз, Инк. Модулятор рецептора эстрогена и его применения
HUE054998T2 (hu) 2015-02-02 2021-10-28 Mei Pharma Inc Kombinációs terápiák emlõrák kezelésében való alkalmazásra
CN109963848B (zh) * 2016-11-17 2022-07-05 赛诺菲 取代的n-(3-氟丙基)-吡咯烷化合物、其制备方法以及其治疗用途
US20200215025A1 (en) * 2017-09-15 2020-07-09 Norbio No. 1 Pty Ltd Treatment of excitotoxicity
CN112225716A (zh) * 2020-10-30 2021-01-15 陕西嘉禾生物科技股份有限公司 一种鹰嘴豆牙素a的合成方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3374245A (en) * 1964-04-01 1968-03-19 Ciba Geigy Corp Unsaturated oxacycles
DE1518002C3 (de) * 1965-01-02 1975-01-23 Merck Patent Gmbh, 6100 Darmstadt Isoflavane und Isoflavene und Verfahren zu Ihrer Herstellung sowie diese enthaltende Arzneimittel
US5280040A (en) * 1993-03-11 1994-01-18 Zymogenetics, Inc. Methods for reducing bone loss using centchroman derivatives
US5985306A (en) * 1996-10-28 1999-11-16 Novo Nordisk A/S (+)-enantiomers of cis-3,4-chroman derivatives useful in prevention or treatment of estrogen diseases or syndromes
CA2269936A1 (en) * 1996-10-28 1998-05-07 Lise Brown Christiansen Novel trans-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
JP3251946B2 (ja) * 1996-12-13 2002-01-28 中外製薬株式会社 新規なベンゾピラン誘導体
KR20000001793A (ko) 1998-06-13 2000-01-15 이경하 신규한 벤조피란 또는 티오벤조피란 유도체
WO2000039120A2 (en) 1998-12-30 2000-07-06 Signal Pharmaceuticals, Inc. Compounds and methods for modulation of estrogen receptors

Also Published As

Publication number Publication date
EP1355906A1 (en) 2003-10-29
DZ3459A1 (fr) 2002-08-01
CN1261431C (zh) 2006-06-28
PT1355906E (pt) 2005-05-31
NO20033318L (no) 2003-09-24
DE60202590T2 (de) 2005-12-29
US20040106595A1 (en) 2004-06-03
CN1487934A (zh) 2004-04-07
NZ527144A (en) 2005-03-24
TNSN03043A1 (en) 2005-12-23
SK287086B6 (sk) 2009-11-05
NO327808B1 (no) 2009-09-28
IL157065A0 (en) 2004-02-08
SK9392003A3 (en) 2003-12-02
EP1355906B1 (en) 2005-01-12
JP2004517151A (ja) 2004-06-10
AU2002237282B2 (en) 2007-02-15
WO2002059113A1 (en) 2002-08-01
ES2236485T3 (es) 2005-07-16
HK1060558A1 (en) 2004-08-13
EA200300727A1 (ru) 2004-02-26
HUP0401018A2 (hu) 2004-09-28
NO20033318D0 (no) 2003-07-23
IL157065A (en) 2010-05-17
JP4332349B2 (ja) 2009-09-16
DK1355906T3 (da) 2005-05-30
US6951883B2 (en) 2005-10-04
CA2435775A1 (en) 2002-08-01
MXPA03006505A (es) 2004-04-21
BR0207066A (pt) 2004-03-30
CZ20032014A3 (cs) 2003-12-17
DE60202590D1 (de) 2005-02-17
ATE286894T1 (de) 2005-01-15
HUP0401018A3 (en) 2007-05-29
PL365062A1 (en) 2004-12-27
MA26982A1 (fr) 2004-12-20
SI1355906T1 (en) 2005-06-30

Similar Documents

Publication Publication Date Title
RU2167849C2 (ru) Нафтилпроизводные или их фармацевтически приемлемые соли, способ их получения, фармацевтическая композиция на их основе и промежуточные вещества
US6964973B2 (en) Bicyclic androgen and progesterone receptor modulator compounds and methods
EP1246814B1 (en) Compounds and methods for modulation of estrogen receptors
EA006158B1 (ru) Производные 2h-1-бензопирана и содержащая их фармацевтическая композиция
AU2002237282A1 (en) 2H-1-Benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof
ZA200210201B (en) Benzofuran Derivatives.
EP2623503B1 (en) Chromene derivatives useful in the treatment of a disease mediated by the tcr-nck interaction
US6043269A (en) cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
Chen et al. Aza analogues of equol: Novel ligands for estrogen receptor β
Gauthier et al. Synthesis and structure–activity relationships of analogs of EM-652 (acolbifene), a pure selective estrogen receptor modulator. Study of nitrogen substitution
EP1229036A1 (en) 2H-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof
EP0937062B1 (en) Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
US5994390A (en) Trans-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
CA2270113A1 (en) Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
US6599921B2 (en) Non-steroidal estrogen receptor ligands
CS241030B2 (en) Method of 1,1,2-triphenylpropane and 1,1,2-triphenylpropene's new derivatives production
HK1060558B (en) 2h-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof
KR101634758B1 (ko) 에스트로겐 수용체 리간드로서의 2-하이드록시-7-메틸 옥타하이드로페난트렌 유도체 또는 이의 약학적으로 허용가능한 염을 유효성분으로 함유하는 약학 조성물
US20010021710A1 (en) Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
US20030092695A1 (en) Metal salts of 3-methyl-chromane or thiochromane derivatives
EP1281710A1 (en) 2H-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof
CZ2000948A3 (cs) Substituované chromanové deriváty

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU